Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Rating of “Buy” by Analysts
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have been assigned an average rating of “Buy” from the ten analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation […]
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have been assigned an average rating of “Buy” from the ten analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation […]
